4.0
13. März 2009
Ehemaliger Mitarbeiter
King of Prussia, PA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
dynamic, business driven, young, practical, adjust fast to the big environment. In 2008 it was the first big pharm company that dares to cut majority of discovery functions and adjust the structure orgnization to big extent. Good company overall. Good health benefit. Good dental benefit.
Kontras
Extremely low pay especially for those hired many years ago, do not encourage publishing paper, do not retain the best scientists. Need to have competative pay, do comaparable market analysis and equity research, so those at who have stayed at the same positions will get the same pay/ or even higher pay than those new hires.